Cancer Research
Studies from Japan and the South Africa describe new findings in cancer research
Published in Virus Weekly, June 13th, 2006
Study 1: Researchers from Japan reported that hepatocellular carcinogenesis (HCC) is reduced by long-term glycyrrhizin injection therapy in patients with interferon (IFN)-resistant active chronic hepatitis C.
"To elucidate the influence of a glycyrrhizin therapy on hepatocarcinogenesis rate in IFN-resistant hepatitis C, we retrospectively analyzed 1249 patients with chronic hepatitis with or without cirrhosis," wrote K. Ikeda and colleagues, Toranomon General Hospital.
They continued, "Among 346 patients with high Ala transaminase value (twice or more of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Virus Weekly
Source: Virus Weekly (2006-06-13)
More Articles from Virus Weekly
- Adenovirus Vaccine
Adenoviral respiratory illness in U.S. military recruits is increasing - Hepatitis C Virus
Hepatitis C virus strain replication is diversely affected by cyclosporine - Influenza Vaccine
Mitigation strategies for pandemic influenza in U.S. are presented - Sexual & Reproductive Health
Serum human papillomavirus type 16 may identify active viral replication in women with HIV - West Nile Virus Pathogenesis
West Nile virus viremia dramatically increased during glucocorticoid treatment - Adenoviral Gene Therapy
Adenovirus-mediated gene expression is improved by a polyethylene glycol vehicle - More from this issue of Virus Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
